Catalogue
Every entry ships lyophilised in argon-purged amber glass (or in pre-filled research pen / nasal-spray format where supplied), batch-tested by an independent analytical lab, and documented with a signed certificate. Category labels describe the research context — they are not indications.
- Entries
- 40
- Median purity
- 99.18%
- Dispatch origin
- Prague · Chiang Mai · UK
- Stock-outs
- 0
Metabolic
Incretin-family peptides. GLP-1, GIP, glucagon, and amylin receptor agonists — including the investigational triple-agonist Retatrutide.
Retatrutide 40 mg pen
Triple-receptor agonist — pre-filled research pen, 4 × 10 mg.
- Form
- Pre-filled pen
- Dose
- 40 mg / 3 mL pen
- Purity
- ≥ 99.2%
Retatrutide 30 mg kit
Triple-receptor agonist — 30 mg vial, full research kit.
- Form
- Lyophilised kit
- Dose
- 30 mg / vial
- Purity
- ≥ 99.2%
Retatrutide 10 mg kit
Triple-receptor agonist — 10 mg vial, full research kit.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.2%
Cagrilintide 10 mg
Long-acting amylin analogue — GLP-1 stack partner.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 98.5%
Regenerative
Peptides studied in tissue repair, wound healing, and cytoskeletal dynamics. BPC-157 and thymosin β-4 dominate the published literature.
BPC-157 + TB-500 10/10 mg kit
Paired regenerative peptides — combined kit, most-requested blend.
- Form
- Lyophilised kit
- Dose
- 10 mg BPC-157 + 10 mg TB-500 / vial
- Purity
- ≥ 99.0% (both peptides)
TB-500 10 mg
Synthetic thymosin β-4 — 43-residue actin-sequestering peptide.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.1%
BPC-157 15 mg
Pentadecapeptide — 15-residue fragment of a gastric body-protection protein.
- Form
- Lyophilised kit
- Dose
- 15 mg / vial
- Purity
- ≥ 99.4%
BPC-157 oral (60 × 500 mcg tablets)
Oral / sublingual tablet presentation — 60 tablets × 500 mcg.
- Form
- Oral tablets
- Dose
- 500 mcg / tablet (60-tablet supply)
- Purity
- ≥ 99.4% active
BPC-157 + TB-500 20/20 mg pen
High-dose pen format — 20 mg BPC-157 + 20 mg TB-500.
- Form
- Pre-filled pen
- Dose
- 20 mg BPC-157 + 20 mg TB-500 (pre-filled pen)
- Purity
- ≥ 99.0%
Dermal
Peptides applied in dermal, cosmetic-formulation, melanocortin, and skin-biology research.
GHK-Cu 100 mg
Copper-bound tripeptide Gly-His-Lys.
- Form
- Lyophilised kit
- Dose
- 100 mg / vial
- Purity
- ≥ 99.6%
GHK-Cu 150 mg pen
Pre-filled copper-tripeptide pen — high-dose presentation.
- Form
- Pre-filled pen
- Dose
- 150 mg / pen
- Purity
- ≥ 99.6%
Glow Blend 70 mg
Multi-peptide dermal blend — GHK-Cu + supporting peptides.
- Form
- Lyophilised kit
- Dose
- 70 mg / vial
- Purity
- ≥ 99.0% (component-level)
Glow Blend 140 mg pen
Pre-filled dermal-blend pen — 140 mg presentation.
- Form
- Pre-filled pen
- Dose
- 140 mg / pen
- Purity
- ≥ 99.0% (component-level)
Melanotan II 10 mg
Melanocortin-receptor agonist — cyclic heptapeptide.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%
Melanotan I 10 mg
Linear α-MSH analogue — MC1R-selective melanocortin agonist.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%
PT-141 10 mg
Approved MC3R/MC4R agonist — cyclic heptapeptide.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%
Snap-8 10 mg
Cosmetic octapeptide — argireline extension analogue.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%
Growth hormone
Secretagogues and GHRH analogues. Ipamorelin, CJC-1295, tesamorelin, sermorelin, plus IGF-1 LR3.
Ipamorelin 10 mg
Selective growth-hormone secretagogue — pentapeptide.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%
CJC-1295 with DAC 5 mg
Long-acting GHRH analogue with Drug Affinity Complex.
- Form
- Lyophilised kit
- Dose
- 5 mg / vial
- Purity
- ≥ 99.0%
CJC-1295 no DAC 10 mg
Short-acting GHRH (1-29) analogue — no DAC linker.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%
Tesamorelin 10 mg
Approved GHRH analogue — stabilised long-acting GRF(1-44).
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%
Sermorelin 10 mg
GHRH(1-29) analogue — the minimum fragment with full GH-releasing activity.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%
GHRP-6 10 mg
Non-selective ghrelin-receptor agonist — hexapeptide.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%
IGF-1 LR3 1 mg
Modified IGF-1 — reduced IGFBP binding, ~83-residue analogue.
- Form
- Lyophilised kit
- Dose
- 1 mg / vial
- Purity
- ≥ 98.0%
Mitochondrial
Mitochondrial-derived peptides and metabolic-support compounds. MOTS-c (discovered 2015), NAD⁺, and ERR-family small molecules.
MOTS-c 40 mg
Mitochondrial-derived 16-residue peptide — high-dose kit.
- Form
- Lyophilised kit
- Dose
- 40 mg / vial
- Purity
- ≥ 99.0%
NAD⁺ 500 mg kit
NAD⁺ coenzyme — 500 mg kit presentation.
- Form
- Lyophilised kit
- Dose
- 500 mg / vial
- Purity
- ≥ 99.0%
NAD⁺ 1000 mg pen
High-dose NAD⁺ pen — 1000 mg pre-reconstituted.
- Form
- Pre-filled pen
- Dose
- 1000 mg / pen
- Purity
- ≥ 99.0%
5-Amino-1MQ 5 mg
NNMT inhibitor — small-molecule metabolic research tool.
- Form
- Lyophilised kit
- Dose
- 5 mg / vial
- Purity
- ≥ 99.0%
AOD9604 5 mg
hGH C-terminal fragment — lipolytic research peptide.
- Form
- Lyophilised kit
- Dose
- 5 mg / vial
- Purity
- ≥ 99.0%
SLU-PP-332 5 mg
Pan-ERR agonist — small-molecule metabolic research tool.
- Form
- Lyophilised kit
- Dose
- 5 mg / vial
- Purity
- ≥ 98.0%
Nootropic
Neural / cognitive research compounds — Russian-registered heptapeptides and the phenothiazine methylene blue.
Semax 11 mg
ACTH-derived heptapeptide — Russian nootropic research peptide.
- Form
- Lyophilised kit
- Dose
- 11 mg / vial
- Purity
- ≥ 99.0%
Semax Nasal 10 mg
Semax in nasal-spray formulation — intranasal delivery research.
- Form
- Nasal spray
- Dose
- 10 mg active / pre-filled spray
- Purity
- ≥ 99.0%
Selank 11 mg
Tuftsin-derived heptapeptide — Russian anxiolytic research peptide.
- Form
- Lyophilised kit
- Dose
- 11 mg / vial
- Purity
- ≥ 99.0%
Selank Nasal 10 mg
Selank in nasal-spray formulation.
- Form
- Nasal spray
- Dose
- 10 mg / pre-filled spray
- Purity
- ≥ 99.0%
DSIP 15 mg
Nonapeptide isolated from cerebral venous blood.
- Form
- Lyophilised kit
- Dose
- 15 mg / vial
- Purity
- ≥ 99.0%
Methylene Blue 100 mL / 30%
Phenothiazine dye — research-grade 30% aqueous solution.
- Form
- Liquid solution
- Dose
- 100 mL of 30% w/v aqueous solution
- Purity
- ≥ 99.0%
Formulation
Proprietary multi-peptide blends for multi-receptor research.
Accessories
Consumables supplied alongside the catalogue — bacteriostatic water, insulin syringes, alcohol swabs.
Extra Syringe Kit
Additional consumables — 20 insulin syringes, swabs.
- Form
- Accessory
- Dose
- N/A
Bacteriostatic water 10 mL
10 mL bacteriostatic water for injection — 0.9% benzyl alcohol.
- Form
- Accessory
- Dose
- N/A
Bacteriostatic water 3 mL
3 mL bacteriostatic water for injection.
- Form
- Accessory
- Dose
- N/A